DCAT Week 2026

Carla Vozone, PharmD Vice President, Specialty Drug Delivery Catalent Pharma Solutions  Carla Vozone, PharmD, MBA, is Vice President of Specialty Drug Delivery at Catalent Pharma Solutions, where she leads the business segment of pulmonary and nasal delivery and bioavailability technologies. She is responsible for Business Development and Commercial Operations and leads Product

Suzanne (Suzie) M. Opalka, Ph.D. Biogen Associate Director, Chemical Process Development

Fernando Otero Associate Vice President, External Manufacturing MSD International Business GmbH  Fernando Otero is Associate Vice President, External Manufacturing. MSD International Business GmbH, where he is responsible for the External

Christina da Cunha Head of CMO Operations and Business Transformation, External Manufacturing & Supply

Karin Shanahan Bristol-Myers Squibb Executive Vice President, Global Product Development & Supply Karin Shanahan is Executive Vice President, Global Product Development

Troy Mathews Executive Director, Direct Materials Strategic Sourcing, Supplier Management & Site Operations, Global Procurement – Global Product Development & Supply Bristol Myers Squibb  Troy Mathews is Executive Director of Direct Materials Strategic Sourcing, Supplier Management, and Site Procurement Operations

Xavier De Ceuninck Category Management Lead, PGS Global Procurement, Source to Pay

Lu Chen, Ph.D. & M.B.A. Managing Director & Partner, Health Care Practice Boston Consulting Group  Lu Chen, Ph.D. & M.B.A., is a Managing Director & Partner at Boston Consulting Group (BCG). She is a core member of BCG’s Health Care, Principal Investor & Private Equity, and Corporate Finance & Strategy

Alejandro Fernandez Director, Product Planning & Fulfillment Cisco Alejandro Fernandez is Director, Product Planning & Fulfillment at Cisco, where he is responsible for the material planning, production capacity analysis, inventory

Derron Stark EY-Parthenon Partner, Strategy & Transactions – Life Sciences, Supply Chain Ernst & Young LLP Derron Stark is an EY-Parthenon Partner, Strategy & Transactions—Life Sciences, Supply Chain, Ernst & Young LLP. He is a leader in the Life Sciences Supply Chain competency of EY-Parthenon, EY’s global strategy and corporate transaction

Graham, Managing Director at Estates 360, brings over two decades of experience delivering estate-related programmes, in both client and consultancy capacities. Specialising in complex organisational programmes, he has led masterplanning, capital project and estate management teams. His educational portfolio includes schools and HE institutions, and ranges from 20 year masterplans to research supercomputing facilities, and from listed building conversions to on-campus transport infrastructure. Beyond educational estates, Graham draws on his experience in operational and delivery roles leading schemes across diverse sectors including local government, healthcare, heritage, infrastructure, retail, commercial, and aviation. Graham's previous roles include Head of Construction, Maintenance, and FM at a local authority, and as Head of a Regional Project Management team at an international consultancy. His focus is on assisting clients in navigating the competing challenges of ageing infrastructure, diminishing funding, net zero commitments, and the impacts of the fourth industrial revolution.

Bala Sreenivasan Senior Vice President, Global Supply and Value Chain Management Merck

Richard DiMarchi, Ph.D. Distinguished Professor of Chemistry and the Gill Chair in Biomolecular Sciences, Indiana University and Former Group Vice President, Eli Lilly and Company and Novo Nordisk Richard DiMarchi, Ph.D., is a globally renowned scientist and former Group Vice President at Eli Lilly and Company and later at Novo Nordisk, who is recognized for his

Michael HoffmanVice President, Process